medigraphic.com
ISSN 0016-3813 (Impreso)

2013, Número 1

<< Anterior Siguiente >>

Gac Med Mex 2013; 149 (1)


Riesgo transfusional del uso de plasma femenino/masculino. Análisis y debate

Mejía DAM

Idioma: Español
Referencias bibliográficas: 28
Paginas: 89-93
Archivo PDF: 96.64 Kb.


RESUMEN

Se ha relacionado con la lesión pulmonar aguda por transfusiones (transfusion-related acute lung injury [TRALI]), que es un síndrome caracterizado por dificultad respiratoria aguda después de la transfusión de componentes sanguíneos. La característica fisiopatológica de TRALI es un aumento de la permeabilidad microvascular pulmonar. Varios informes demuestran que la mayoría de los casos TRALI se precipitan por la transfusión de anticuerpos de donantes dirigidos contra antígenos humanos leucocitarios (HLA) o antígenos humanos de neutrófilos (HNA) expresada en la superficie de los neutrófilos de los del receptor. Esta interacción antígeno-anticuerpo se cree que causa la activación de los neutrófilos directamente y liberación de agentes citotóxicos, con el subsecuente daño endotelial y fuga capilar. Después de la transfusión de plasma se presenta un evento adverso importante no detectado. Algunos centros de sangre han limitado la recolección de plasma de las donantes mujeres que han tenido hijos, debido a su propensión a desarrollar anticuerpos anti-HLA después del embarazo.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Szczepiorkowski ZM, Winters JL, Bandarenko N, et al. Guidelines on the uses of therapeutic apheresis in clinical practice-evidence-based approach from the apheresis applications committee of the American Society for Apheresis. J Clin Apher. 2010;25:83-177.

  2. Rodríguez MH. Insuficiencia respiratoria pulmonar aguda y transfusión. En: Martínez J, D’Artote AL, eds. Medicina transfusional. Ediciones AMMTAC; impreso en México 2012, p. 460-6.

  3. Guía para el uso clínico de la sangre. Publicación original de la Secretaría de Salud, la Asociación Mexicana de Medicina Transfusional A.C. y la Agrupación Mexicana para el Estudio de la Hematología. impreso en México, tercera edición enero 2007. Secretaría de Salud. p. 1-175.

  4. Roback JD, Caldwell S, Carson J, et al. Evidence based practice guidelines for plasma transfusion. Transfusion. 2010;50:1227-39.

  5. Silliman CC, Fung YL, Ball BB, et al. Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev. 2009;23:245-55.

  6. Robillard P, Vik J, Hyson C. Trends in adverse transfusion events related to blood components reported to the Canadian Transfusion Transmitted Injuries Surveillance System 2002-2007. Vox Sang. 2010;99 Suppl 1:460.

  7. Robillard P, Nawej K, Chapdelaine A. Transfusion Associated Circulatory overload (TACO): the leading cause of transfusion associated fatalities in the Quebec Hemovigilance System. Vox Sang. 2010;99 Suppl 1:456-7.

  8. Davis A, Mandal R, Johnson M, et al. A touch of TRALI. Transfusion. 2008;48:541-5.

  9. Danielson C, Benjamin RJ, Mangano MM, Mills CJ, Waxman DA. Pulmonary pathology of rapidly fatal transfusion-related acute lung injury reveals minimal evidence of difusse alveolar damage or alveolar granulocyte infiltration. Transfusion. 2008;48:2401-8.

  10. Middelburg RA, Van Stein D, Briet E, et al. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion. 2008;48:2167-76.

  11. Fung YL, Silliman CC. The role of neutrophils in the pathogenesis of transfusion- related acute lung injury (TRALI). Transfus Med Rev. 2009;23:266-83.

  12. Reil A, Keller-Stanislawski B, Gunay S, et al. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang. 2008;95:313-7.

  13. Lima J, Reddy Vishnu VB, Marques MB. System in neutrophil aggregates in transfusion-related acute lung injury. Transfusion. 2010;50:1427-8.

  14. Sachs UJ, Wasel W, Bayat B, et al. Mechanism of transfusion related acute lung injury induced by HLA class II antibodies. Blood. 2011; 117:669-77.

  15. Khan SY, Kelher MR, Heal JM, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood. 2006;108:2455-62.

  16. Tung JP, Fraser JF, Nataatmadja M, et al. Dissimilar respiratory and hemodynamic responses in TRALI induced by stored red cells and whole blood platelets. Blood. 2010;116:1112.

  17. Sakagawa H, Miyazaki T, Fujihara M, et al. Generation of inflammatory cytokines and chemokines from peripheral blood mononuclear cells by HLA class II antibody-containing plasma unit that was associated with severe on hemolytic transfusion reactions. Transfusion. 2007;47:154-61.

  18. Cooling L. Transfusion-related acute lung injury. JAMA. 2002;288:315-6.

  19. Toy P, Hollis-Perry KM, Jun J, et al. Recipients of blood from a donor with multiple HLA antibodies: a look back study of transfusion-related acute lung injury. Transfusion. 2004;44:1683-8.

  20. Makar RS, Saidman SL, Stowell CP, et al. Analysis of cutoffs for screening sensitized blood donors for HLA alloantibodies using a cytometric microbead assay. Transfusion. 2011;51:166-74.

  21. Middelburg RA, Van Stein D, Zupanska B, et al. Female donors and transfusion-related acute lung injury: a case-referent study from the International TRALI Unisex Research Group. Transfusion. 2010;50:2447-54.

  22. Eder AF, Herron RM Jr, Strupp A, et al. Effective reduction of transfusion- related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion. 2010; 50:1732-42.

  23. Nakazawa H, Ohnishi H, Okazaki H, et al. Impact of fresh-frozen plasma from male-only donors versus mixed-sex donors on postoperative respiratory function in surgical patients: a prospective case-controlled study. Transfusion. 2009;49:2434-41.

  24. SHOT Annual Report Manchester 2009. TRALI investigations 2009-2011. ISBT Sci Ser. 2011;6:206-11.

  25. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion related acute lung injury (TRALI) risk reduction strategy 2009. ISBT Sci Ser. 2011;6:206-11.

  26. Tung JP, Fung YL, Nataatmadja M, et al. A novel in vivo ovine model of transfusion-related acute lung injury (TRALI). Vox Sang. 2011;100:219-30.

  27. Sweeney JD, Tavares M, Conti G, DeQuatro P, Nolette NL. Reduction in the use of FFP over a ten years period after implementing an educational and enforcement program. Vox Sang. 2010;99 Suppl 1:17.

  28. Santoso S, Sachs UJ. New insights in mechanisms of transfusion-related acute lung injury. ISBT Sci Ser. 2012;7:124-8.




2020     |     www.medigraphic.com